Clinical Outcomes Following Treatment With SYSTANE® BALANCE

Inclusion Criteria:

- Willing and able to attend all study visits;

- Must sign an informed consent form;

- Best-corrected visual acuity (BCVA) of 55 letters or better in each eye as assessed
using an early treatment diabetic retinopathy study (ETDRS) chart;

- Willing to take study products as directed for entire study;

- Other protocol-specified inclusion criteria may apply.

Exclusion Criteria:

- Women of childbearing potential who are pregnant, plan to become pregnant during the
study, breast feeding, or not using adequate birth control methods;

- Contact lens use within 30 days prior to Screening Visit, or unwilling to avoid
contact lens use during the course of the study;

- Use of medication excluded by the protocol;

- Diseases, illnesses, infections, or ocular abnormalities excluded by the protocol;

- Ocular surgeries or procedures excluded by the protocol;

- Other protocol-specified exclusion criteria may apply.